Transfer Addiction After Bariatric Surgery

Transfer addiction after bariatric surgery is a recognised clinical concern in which a person replaces compulsive eating with a new addictive behaviour or substance dependency following weight-loss surgery. Procedures such as Roux-en-Y gastric bypass and sleeve gastrectomy reduce physical food intake, but if the underlying psychological and neurological drivers of reward-seeking are not addressed, the brain may seek stimulation elsewhere. Alcohol, gambling, compulsive spending and prescription medication misuse are among the most commonly reported examples. Understanding the risk factors, warning signs and available support is an essential part of responsible post-operative care.

What is transfer addiction and why does it happen after bariatric surgery?

Transfer addiction occurs when the brain's reward-seeking behaviour shifts from food to a new compulsive behaviour or substance after bariatric surgery, driven by unchanged neurological reward pathways. Physiological changes, particularly altered alcohol metabolism after gastric bypass, can further increase vulnerability.

Transfer addiction, sometimes called addiction transfer or cross-addiction, is a phenomenon in which a person who has undergone bariatric surgery develops a new compulsive behaviour or substance dependency after surgery, often in place of their previous relationship with food. It is recognised by bariatric specialists and addiction researchers as a genuine clinical concern, though the precise prevalence is difficult to establish because definitions and study designs vary across the literature.

The underlying mechanism is thought to involve the brain's reward pathways. For many people living with obesity, food, particularly highly palatable food rich in sugar and fat, is believed to activate dopamine release in ways that parallel other addictive substances. After bariatric procedures such as Roux-en-Y gastric bypass or sleeve gastrectomy, the physical capacity to eat large quantities is dramatically reduced. If the psychological and neurological drivers of reward-seeking behaviour have not been addressed, the brain may seek an alternative source of stimulation. These mechanistic explanations are supported by observational and neuroimaging research, though the evidence base continues to develop and some aspects remain areas of active investigation.

Physiological changes following surgery may also play a role. Gastric bypass in particular alters the absorption and metabolism of alcohol, meaning that alcohol reaches the bloodstream more rapidly and at higher concentrations than before surgery.^[2][3] This pharmacokinetic change can make alcohol more reinforcing and may lower the threshold at which dependency develops. For this reason, many bariatric services, including those following British Obesity and Metabolic Surgery Society (BOMSS) guidance, advise patients to avoid alcohol entirely in the early post-operative period and to exercise particular caution thereafter.^[6] Hormonal shifts, including changes in ghrelin and other gut hormones, may further influence mood, impulse control and reward sensitivity in the post-operative period, though the precise contribution of each factor is not yet fully established.^[9]

It is important to emphasise that transfer addiction does not affect everyone who has bariatric surgery, and surgery remains a clinically effective intervention for obesity and its associated conditions. Awareness of the risk, however, is an essential part of responsible pre- and post-operative care.

Which behaviours and substances are most commonly involved?

Alcohol is the most commonly studied substance, with cohort data showing significantly increased rates of alcohol use disorder after gastric bypass. Other reported behaviours include gambling, compulsive shopping, recreational drug use, and loss-of-control eating.

Alcohol is the most extensively studied substance in the context of transfer addiction after bariatric surgery, with observational research consistently identifying an increased risk of alcohol use disorder in the years following gastric bypass in particular. Data from the Longitudinal Assessment of Bariatric Surgery (LABS) cohort, published in JAMA and related journals, found that rates of alcohol use disorder were significantly higher two or more years after surgery compared with the pre-operative period, particularly following Roux-en-Y gastric bypass.^[1] These findings are consistent with several systematic reviews and meta-analyses in the peer-reviewed literature, though the absolute risk varies across studies depending on how alcohol use disorder is defined and measured.

Beyond alcohol, a range of other substances and behaviours have been reported in clinical practice and the research literature:

• Gambling, including online gambling, which can escalate rapidly given its accessibility

• Shopping and spending, sometimes described as compulsive buying disorder

• Recreational drug use, including cannabis and stimulants

• Prescription medication misuse, particularly opioid analgesics and anxiolytics

• Compulsive exercise, which may initially appear positive but can become harmful

• Sexual behaviour, including risky or compulsive sexual activity

• Internet and gaming use, which shares reward-pathway characteristics with other behavioural addictions

These behavioural examples are drawn from observational studies and clinical case series rather than large randomised trials, and should be understood in that context. Food-related behaviours can also persist or transform after surgery. Binge eating disorder may re-emerge in a modified form, sometimes called loss-of-control eating, even when the volume consumed is small.^[20][21] Grazing, the repeated consumption of small amounts throughout the day, can serve a similar psychological function to pre-operative overeating.

The common thread across these behaviours is their capacity to produce rapid, reliable changes in mood and arousal, which is precisely what the reward system seeks when its primary outlet, in this case food, has been restricted.

For those concerned about gambling specifically, NHS gambling treatment services are available and can be accessed via the NHS website or through a GP referral.

Am I more at risk of developing transfer addiction after weight-loss surgery?

Risk is highest in people with a personal or family history of substance use disorder, pre-existing mental health conditions, or high impulsivity, and is greater after Roux-en-Y gastric bypass than sleeve gastrectomy. Comprehensive pre- and post-operative psychological support significantly reduces this risk.

Certain factors are associated with a higher likelihood of developing transfer addiction after bariatric surgery, and identifying them before the operation is a key part of pre-operative psychological assessment. A personal or family history of substance use disorder, including alcohol dependency, is one of the strongest predictors identified in cohort studies.^[9] People who have previously used food as a primary coping mechanism for stress, anxiety, depression or trauma are also considered at elevated risk, because the psychological function that food served does not disappear when the stomach is reduced in size.

Pre-existing mental health conditions, including depression, anxiety disorders, post-traumatic stress disorder and attention deficit hyperactivity disorder (ADHD), are associated with increased vulnerability. Impulsivity, as a personality trait rather than a diagnosis, has also been identified in research as a relevant factor, since impulsive individuals may be more susceptible to rapid reward-seeking in new domains.

The type of surgical procedure matters too. Roux-en-Y gastric bypass carries a higher documented risk of alcohol use disorder than sleeve gastrectomy, likely because of the more pronounced changes in alcohol absorption and metabolism that follow bypass anatomy.^[7][8] Age at surgery, social support networks and post-operative follow-up engagement are additional variables that influence risk.

It is worth noting that risk factors are not destiny. Many people with several of these characteristics do not develop transfer addiction, particularly when they receive comprehensive psychological support before and after surgery. NICE guidance on obesity management recommends that bariatric surgery is provided within a specialist multidisciplinary team that includes psychological assessment and support, and patients should expect this to be offered as standard within NHS bariatric services.^[10][11] Access to specific services and referral pathways will depend on local NHS Integrated Care Board (ICB) arrangements, so it is worth asking your bariatric team what is available in your area.

BOMSS publishes guidance for both professionals and patients on the psychological aspects of bariatric surgery, including pre-operative assessment, and this can be a useful resource for anyone wanting to understand what to expect.

What are the warning signs that a new addiction may be developing?

Key warning signs include drinking more than intended, spending excessive time on a behaviour at the expense of relationships or work, concealing the behaviour, and continuing despite negative consequences. Anyone recognising these signs should speak to their GP, who can refer to appropriate NHS services.

Recognising transfer addiction early significantly improves the chances of successful intervention, and both patients and those close to them should be aware of the behavioural and psychological signs that may indicate a problem is developing. The warning signs often emerge gradually and may initially be dismissed as understandable responses to the stress of major surgery and significant life change.

Key warning signs to be aware of include:

• Drinking alcohol more frequently or in larger amounts than intended, or finding it difficult to stop after one or two drinks. It is important to note that even small amounts of alcohol can have a disproportionately strong effect after gastric bypass, and patients are generally advised to avoid driving after any alcohol consumption post-surgery

• Spending increasing amounts of time on a particular behaviour, such as gambling, gaming or shopping, at the expense of work, relationships or self-care

• Using a substance or behaviour to manage difficult emotions, including boredom, loneliness, anxiety or low mood

• Feeling irritable, restless or anxious when unable to engage in the behaviour

• Concealing the behaviour from family members, friends or healthcare professionals

• Continuing despite negative consequences, such as financial difficulties, relationship strain or physical harm

• Experiencing cravings or preoccupation with the substance or behaviour between episodes

• Needing to escalate the behaviour to achieve the same effect

It is also worth monitoring changes in mood and sleep, as these can be early indicators of an emerging dependency. Post-operative depression is not uncommon and can both trigger and mask addictive behaviour.

Anyone who recognises these signs in themselves should speak to their GP in the first instance. GPs can refer to NHS Talking Therapies (find your local service at nhs.uk/mental-health/talking-therapies-medicine-treatments/talking-therapies-and-counselling/nhs-talking-therapies), NHS drug and alcohol services (searchable at nhs.uk/service-search/find-drug-and-alcohol-addiction-services), or back to the bariatric team depending on the nature and severity of the concern.

If you are in immediate danger of harming yourself or others, call 999 or go to your nearest A&E department. For urgent mental health support that is not an immediate emergency, call NHS 111 and select the mental health option, or contact your local NHS urgent mental health helpline, details of which are available through NHS 111 or the NHS website.

Long-term support and relapse prevention after bariatric surgery

Cognitive behavioural therapy and motivational interviewing are evidence-based approaches available through NHS Talking Therapies and specialist addiction services. NICE recommends at least two years of multidisciplinary follow-up after bariatric surgery, including psychological support.

Long-term psychological support is the most effective strategy for preventing and managing transfer addiction after bariatric surgery, and it should be considered an integral part of the post-operative pathway rather than an optional extra. NICE guidance on obesity management recommends that bariatric surgery is provided within a specialist multidisciplinary team that includes psychological support, and NHS service specifications generally expect follow-up to continue for at least two years after the procedure.^[10][11] Patients should ask their bariatric team what follow-up is available to them and how to access it.

Cognitive behavioural therapy (CBT) is well-supported by evidence for addressing both disordered eating and substance use, and it can be adapted to target the reward-seeking patterns that underlie transfer addiction.^[18][19] Motivational interviewing is another approach used within NHS addiction services that can help individuals explore ambivalence about change. Both approaches are available through NHS Talking Therapies and specialist addiction services, depending on the nature of the concern.

For alcohol use disorder specifically, NICE guidance (CG115) recommends pharmacological treatments alongside psychological therapy. Acamprosate and naltrexone are among the options a prescriber may consider. It is important to note that naltrexone is contraindicated in people who require opioid analgesics, so any patient with ongoing pain management needs should discuss this with their prescriber before starting naltrexone.^[16][17] These decisions should always be made in consultation with a GP or specialist who can review the full clinical picture.

Peer support groups, including those specifically designed for bariatric patients, can provide a sense of community and shared understanding that professional services alone may not replicate. BOMSS can signpost patients to appropriate resources, and their website includes patient-facing information on life after bariatric surgery.

For those seeking an initial assessment or ongoing weight-management support in a structured clinical setting, Bolt Pharmacy is a GPhC-registered online pharmacy in Great Britain offering online weight-management consultations, with prescriber review and pharmacist support, as part of a broader approach to long-term health.

Patients and carers should be aware that suspected adverse effects of any medication used in the post-operative period can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Staying engaged with the bariatric team, attending follow-up appointments and being honest about new behaviours are the most important steps any patient can take to protect their long-term wellbeing.

Scientific References

1. Prevalence of Alcohol Use Disorders Before and After Bariatric Surgery (LABS cohort).
2. Blood alcohol concentrations rise rapidly and extensively after Roux-en-Y gastric bypass.
3. Effect of Roux-en-Y Gastric Bypass Surgery on the pharmacokinetics and subjective effects of ingested alcohol.
4. Ethanol pharmacokinetics before and after sleeve gastrectomy and Roux-en-Y gastric bypass: a 3 year prospective study (the BAR-TRIAL).
5. Ethanol Pharmacokinetics and Alcohol-Related Effects after One-Anastomosis Gastric Bypass.
6. Alcohol and bariatric surgery: review and suggested recommendations.
7. Association Between Bariatric Surgery and Alcohol Use Disorder-Related Hospitalizations.
8. Rates of de novo alcohol use disorder and de novo high-risk alcohol use after bariatric surgery: a systematic review and meta-analysis.
9. Addiction Transfer and Other Behavioral Changes Following Bariatric Surgery.
10. Overweight and obesity management (NG246) – Medicines and surgery chapter.
11. NICE-Accredited Commissioning Guidance for Weight Assessment and Management Clinics: a Model for a Specialist Multidisciplinary Team Approach.
12. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence (CG115).
13. Alcohol-use disorders (CG115) – Recommendations chapter.
14. Alcohol-use disorders (CG115) – Treatments for adults who misuse alcohol (patient information).
15. Clinical guidelines for alcohol treatment – pharmacological interventions.
16. Naltrexone hydrochloride – BNF NICE.
17. Naltrexone hydrochloride Patient Information Leaflet.
18. Eating disorders: recognition and treatment (NG69).
19. Cognitive behavioural therapy (CBT) – NHS.
20. Loss of Control Eating and Binge Eating in the 7 Years Following Bariatric Surgery.
21. Binge eating, binge eating disorder and loss of control eating: effects on weight outcomes after bariatric surgery.
22. Binge Eating Before and After Bariatric Surgery.

Frequently Asked Questions